TRT(SH:600085) Chang Jiang Shang Bao·2025-12-17 00:19Core Viewpoint - The long-established brand Tong Ren Tang (600085.SH) is embroiled in a scandal regarding the authenticity of its Antarctic krill oil product, which has been found to contain no phospholipids despite claims of a 43% content [1][2]. Group 1: Product Scandal - The Shanghai Consumer Protection Commission released test results showing that a product labeled "Beijing Tong Ren Tang 99% High Purity Antarctic Krill Oil" had a phospholipid content of 0, raising suspicions of fraud [1][2]. - The product was sold at prices ranging from 35 to 100 yuan on various e-commerce platforms, with misleading claims about its quality and content [2]. - Tong Ren Tang has ordered the involved company, Anhui Habao Pharmaceutical Co., to cease distribution of the product and has initiated legal action against them for unauthorized use of its brand [3]. Group 2: Historical Issues - Tong Ren Tang has faced multiple product quality issues over the years, including incidents involving excessive nitrite levels, illegal additives, and contamination [5][6]. - The company has been involved in various scandals, such as the "honey incident" in 2018 and the mercury contamination in its Ren Dan product in 2024 [4][5]. Group 3: Financial Performance - The company's revenue and net profit have been declining, with a reported revenue of 133.08 billion yuan and a net profit of 11.78 billion yuan in the first three quarters of 2025, representing year-on-year declines of 3.70% and 12.78%, respectively [8]. - In 2024, the company experienced a slowdown in growth, with revenue of 185.97 billion yuan, a mere 4.12% increase, and a net profit decline of 8.54% [7][8]. - The market performance has also been poor, with the stock price dropping from 64.28 yuan per share in May 2023 to around 33 yuan by December 2025, resulting in a market capitalization of approximately 450 billion yuan, significantly lower than competitors like Yunnan Baiyao and Pian Zai Huang [8].